Literature DB >> 23780824

Quality of life is significantly impaired in long-term survivors of acute liver failure and particularly in acetaminophen-overdose patients.

Amol S Rangnekar1, Caitlyn Ellerbe, Valerie Durkalski, Brendan McGuire, William M Lee, Robert J Fontana.   

Abstract

Functional outcomes for long-term survivors of acute liver failure (ALF) are not well characterized. The aim of this prospective study was to determine health-related quality of life in long-term adult ALF survivors. Acute Liver Failure Study Group registry participants completed the Centers for Disease Control and Prevention Health-Related Quality of Life 14 and Short Form 36 (SF-36) questionnaires at 1- and/or 2-year follow-up study visits. Responses were compared among ALF subgroups and to those for available general US population controls. Among the 282 adult ALF patients, 125 had undergone liver transplantation (LT), whereas 157, including 95 acetaminophen overdose (APAP) patients and 62 non-APAP patients, were spontaneous survivors (SSs). APAP SS patients reported significantly lower general health scores and more days of impaired mental and physical health, activity limitations due to poor health, pain, depression, and anxiety in comparison with the other groups (P ≤ 0.001). There were no significant differences in coma grade or in the use of mechanical ventilation or intracranial pressure monitoring among the patient groups during their ALF hospitalization, but APAP SSs had significantly higher rates of psychiatric disease and substance abuse (P < 0.001). In comparison with the general US population, a greater proportion of the combined SS patients reported fair or poor health and ≥14 days of impaired physical/mental health and activity limitations due to poor health. In addition, a greater proportion of LT recipients reported ≥14 days of impaired physical/mental health. Similar results were observed with the SF-36 across the 3 ALF subgroups and in comparison with population controls. In conclusion, long-term adult survivors of ALF reported significantly lower quality of life scores than US population controls. Furthermore, APAP SS patients reported the lowest quality of life scores, possibly because of higher rates of premorbid psychiatric and substance abuse disorders.
© 2013 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23780824      PMCID: PMC3775983          DOI: 10.1002/lt.23688

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  36 in total

1.  Quality of life up to 30 years following liver transplantation.

Authors:  Rajendra Desai; Neville V Jamieson; Alexander E Gimson; Christopher J Watson; Paul Gibbs; J Andrew Bradley; Raaj K Praseedom
Journal:  Liver Transpl       Date:  2008-10       Impact factor: 5.799

2.  Cognitive, mood and quality of life impairments in a select population of ARDS survivors.

Authors:  Mark E Mikkelsen; William H Shull; Rosette C Biester; Darren B Taichman; Sarah Lynch; Ejigayehu Demissie; John Hansen-Flaschen; Jason D Christie
Journal:  Respirology       Date:  2009-01       Impact factor: 6.424

3.  Pre-existing disease: the most important factor for health related quality of life long-term after critical illness: a prospective, longitudinal, multicentre trial.

Authors:  Lotti Orwelius; Anders Nordlund; Peter Nordlund; Eva Simonsson; Carl Bäckman; Anders Samuelsson; Folke Sjöberg
Journal:  Crit Care       Date:  2010-04-15       Impact factor: 9.097

4.  Long-term outcomes of emergency liver transplantation for acute liver failure.

Authors:  Gabriel Chan; Ali Taqi; Paul Marotta; Mark Levstik; Vivian McAlister; William Wall; Douglas Quan
Journal:  Liver Transpl       Date:  2009-12       Impact factor: 5.799

5.  Changes in quality of life and sexual health are associated with low-dose peginterferon therapy and disease progression in patients with chronic hepatitis C.

Authors:  K K Snow; H L Bonkovsky; R J Fontana; H-Y Kim; R K Sterling; A M Di Bisceglie; T R Morgan; J L Dienstag; M G Ghany
Journal:  Aliment Pharmacol Ther       Date:  2010-01-12       Impact factor: 8.171

6.  Six-month outcome in acute kidney injury requiring renal replacement therapy in the ICU: a multicentre prospective study.

Authors:  B Delannoy; B Floccard; F Thiolliere; M Kaaki; M Badet; S Rosselli; C E Ber; A Saez; G Flandreau; Claude Guérin
Journal:  Intensive Care Med       Date:  2009-08-20       Impact factor: 17.440

7.  Gender differences in coronary heart disease and health-related quality of life: findings from 10 states from the 2004 behavioral risk factor surveillance system.

Authors:  Earl S Ford; Ali H Mokdad; Chaoyang Li; Lisa C McGuire; Tara W Strine; Catherine A Okoro; David W Brown; Matthew M Zack
Journal:  J Womens Health (Larchmt)       Date:  2008-06       Impact factor: 2.681

8.  Health-related quality of life after liver transplantation for adult recipients.

Authors:  Hillary Bownik; Sammy Saab
Journal:  Liver Transpl       Date:  2009-11       Impact factor: 5.799

9.  Quality of life and functional outcome at 3, 6 and 12 months after acute necrotising pancreatitis.

Authors:  Stephen E Wright; Rajiv Lochan; Karen Imrie; Catherine Baker; Ian D Nesbitt; Andrew J Kilner; Richard M Charnley
Journal:  Intensive Care Med       Date:  2009-08-14       Impact factor: 17.440

10.  Outcomes of liver transplantation for paracetamol (acetaminophen)-induced hepatic failure.

Authors:  Sheldon C Cooper; Roland C Aldridge; Tahir Shah; Kerry Webb; Peter Nightingale; Sue Paris; Bridget K Gunson; David J Mutimer; James M Neuberger
Journal:  Liver Transpl       Date:  2009-10       Impact factor: 5.799

View more
  7 in total

1.  Impact of perioperative liver dysfunction on in-hospital mortality and long-term survival in infective endocarditis patients.

Authors:  M Diab; C Sponholz; C von Loeffelholz; P Scheffel; M Bauer; A Kortgen; T Lehmann; G Färber; M W Pletz; T Doenst
Journal:  Infection       Date:  2017-08-30       Impact factor: 3.553

2.  Two-year outcomes in initial survivors with acute liver failure: results from a prospective, multicentre study.

Authors:  Robert J Fontana; Caitlyn Ellerbe; Valerie E Durkalski; Amol Rangnekar; Rajender K Reddy; Todd Stravitz; Brendan McGuire; Timothy Davern; Adrian Reuben; Iris Liou; Oren Fix; Daniel R Ganger; Raymond T Chung; Mike Schilsky; Steven Han; Linda S Hynan; Corron Sanders; William M Lee
Journal:  Liver Int       Date:  2014-07-28       Impact factor: 5.828

3.  The role of hepatitis E virus infection in adult Americans with acute liver failure.

Authors:  Robert John Fontana; Ronald E Engle; Steven Scaglione; Victor Araya; Obaid Shaikh; Holly Tillman; Nahid Attar; Robert H Purcell; William M Lee
Journal:  Hepatology       Date:  2016-06-23       Impact factor: 17.425

4.  Clinical and economic characteristics of emergency department visits due to acetaminophen toxicity in the USA.

Authors:  Ahmed Altyar; Lama Kordi; Grant Skrepnek
Journal:  BMJ Open       Date:  2015-09-09       Impact factor: 2.692

5.  Nationwide longitudinal analysis of acute liver failure in taiwan.

Authors:  Cheng-Maw Ho; Chih-Hsin Lee; Jann-Yuan Wang; Po-Huang Lee; Hong-Shiee Lai; Rey-Heng Hu
Journal:  Medicine (Baltimore)       Date:  2014-06       Impact factor: 1.889

6.  Severity of chronic Lyme disease compared to other chronic conditions: a quality of life survey.

Authors:  Lorraine Johnson; Spencer Wilcox; Jennifer Mankoff; Raphael B Stricker
Journal:  PeerJ       Date:  2014-03-27       Impact factor: 2.984

7.  Role of Hepatitis E Virus Infection in North American Patients With Severe Acute Liver Injury.

Authors:  Robert J Fontana; Ronald E Engle; Michelle Gottfried; Bilal Hammed; James Hanje; Valerie Durkalski; David E Kleiner; Hanh Nguyen; Norihisa Nishimura; William M Lee; Patrizia Farci
Journal:  Clin Transl Gastroenterol       Date:  2020-11       Impact factor: 4.396

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.